Cargando…

Geometric tumor embolic budding characterizes inflammatory breast cancer

PURPOSE: Inflammatory breast cancer (IBC) is characterized by numerous tumor emboli especially within dermal lymphatics. The explanation remains a mystery. METHODS: This study combines experimental studies with two different IBC xenografts with image algorithmic studies utilizing human tissue microa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Modi, Arnav P., Nguyen, Julie P. T., Wang, Justin, Ahn, Jonathan S., Libling, William A., Klein, Jacob M., Mazumder, Preeanka, Barsky, Sanford H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Preclinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734724/ https://www.ncbi.nlm.nih.gov/pubmed/36473978 http://dx.doi.org/10.1007/s10549-022-06819-6

Ejemplares similares

High tumor budding stratifies breast cancer with metastatic properties
por: Salhia, Bodour, et al.
Publicado: (2015)

Improved pharmacokinetic and pharmacodynamic profile of a novel PEGylated native Erwinia chrysanthemi L-Asparaginase
por: Modi, Tapasvi, et al.
Publicado: (2021)

Inflammatory breast cancer (IBC): clues for targeted therapies
por: Fernandez, Sandra V., et al.
Publicado: (2013)

The influence of sex and estrous cyclicity on cocaine and remifentanil demand in rats
por: Lacy, Ryan T., et al.
Publicado: (2019)

Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients
por: Bingham, Catherine, et al.
Publicado: (2017)

Dysregulation of the histone demethylase KDM6B in alcohol dependence is associated with epigenetic regulation of inflammatory signaling pathways
por: Johnstone, Andrea L., et al.
Publicado: (2019)

ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer
por: Ku, Bo Mi, et al.
Publicado: (2022)

Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer
por: Ku, Bo Mi, et al.
Publicado: (2019)

Methamphetamine self‐administration reduces alcohol consumption and preference in alcohol‐preferring P rats
por: Winkler, Madeline C., et al.
Publicado: (2016)

Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
por: Wu, Natalie C., et al.
Publicado: (2018)

Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer
por: Zhang, Hua, et al.
Publicado: (2015)

Abstract 25 Cord Blood Mononuclear Cells and Cord Blood Plasma Alter Human Cardiac Endothelial Cell Angiogenic Sprouting and Growth In Vitro
por: Chuang, Angela, et al.
Publicado: (2023)

A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer
por: Lee, Sae Byul, et al.
Publicado: (2018)

Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes
por: Friedland, Julie C., et al.
Publicado: (2013)

Differential nucleobase protection against 5-fluorouracil toxicity for squamous and columnar cells: implication for tissue function and oncogenesis
por: Vanden Heuvel, John P., et al.
Publicado: (2015)

Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors
por: Nguyen, Frédérique, et al.
Publicado: (2017)

Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance
por: Abadie, Jérôme, et al.
Publicado: (2017)

Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression
por: Skibicka, Karolina P, et al.
Publicado: (2012)

Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
por: Wardell, Suzanne E., et al.
Publicado: (2019)

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
por: Thakkar, A., et al.
Publicado: (2016)

Adult rat cortical thickness changes across age and following adolescent intermittent ethanol treatment
por: Vetreno, Ryan P., et al.
Publicado: (2016)

Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data
por: Orucevic, Amila, et al.
Publicado: (2017)

A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer
por: Speransky, S., et al.
Publicado: (2019)

Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation
por: Vihervuori, H., et al.
Publicado: (2022)

Chemotherapy in vivo against M109 murine lung carcinoma with cytochalasin B by localized, systemic, and liposomal administration
por: Trendowski, Matthew, et al.
Publicado: (2015)

Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models
por: Trendowski, Matthew, et al.
Publicado: (2015)

Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach
por: Leal, Mariana Ferreira, et al.
Publicado: (2019)

Inhibition of alpha7 nicotinic receptors in the ventral hippocampus selectively attenuates reinstatement of morphine‐conditioned place preference and associated changes in AMPA receptor binding
por: Wright, Victoria L., et al.
Publicado: (2018)

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
por: Jansen, M. P. H. M., et al.
Publicado: (2011)

Effects of the combination of TRC105 and bevacizumab on endothelial cell biology
por: Liu, Yingmiao, et al.
Publicado: (2014)

Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile
por: Suelmann, B. B. M., et al.
Publicado: (2021)

Effects of mTOR inhibitors and cytoskeletal-directed agents alone and in combination against normal and neoplastic hematopoietic cells in vitro
por: Trendowski, Matthew, et al.
Publicado: (2015)

Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2007)

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
por: Engels, C. C., et al.
Publicado: (2015)

Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer
por: Korobeynikov, Vladislav, et al.
Publicado: (2019)

Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer
por: Kariri, Yousif, et al.
Publicado: (2022)

The availability of drug by liposomal drug delivery: Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate
por: Smits, Evelien A. W., et al.
Publicado: (2018)

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients
por: Engstrøm, M. J., et al.
Publicado: (2013)

Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis
por: Lewis Phillips, Gail D., et al.
Publicado: (2017)

Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer
por: Kariri, Yousif A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rdv2h6rqguvtopf2u6ul85f9uo